Literature DB >> 11420709

Structural and functional analysis of a chimeric protein COL1A1-PDGFB generated by the translocation t(17;22)(q22;q13.1) in Dermatofibrosarcoma protuberans (DP).

M P Simon1, M Navarro, D Roux, J Pouysségur.   

Abstract

Dermatofibrosarcoma protuberans (DP), an infiltrative skin tumour of intermediate malignancy, presents specific cytogenetic features such as reciprocal translocations t(17;22)(q22;q13.1) or supernumerary ring chromosomes derived from t(17;22). We have previously shown that both rings and translocated chromosomes derived from t(17;22) presented the same molecular rearrangement with fusion of the COL1A1 gene on chromosome 17 to the PDGFB gene on chromosome 22. To study the structure and function of the COL1A1-PDGFB chimeric protein, we used a tumour-derived chimeric COL1A1-PDGFB cDNA to perform stable and transient transfections in the Chinese hamster lung fibroblastic cell line PS200 and the human epithelial cell line HEK293. We demonstrated that the stably transfected clones that expressed the COL1A1-PDGFB chimeric protein became growth factors independent and tumorigenic in nude mice. In addition, COL1A1-PDGFB transfected cell supernatants significantly stimulated fibroblastic cell growth, through the activation of the PDGFB receptor pathway. By using anti-PDGFB and specific anti-COL1A1-PDGFB antibodies, we showed that, similar to PDGFB, the COL1A1-PDGFB chimeric proteins are processed in transfected cells into mature PDGFB dimers. These results strongly suggest that the COL1A1-PDGFB chimeric gene expression associated with DP, induces tumours formation through production of mature PDGFB, in an autocrine or paracrine way. Strikingly, mutagenesis experiments indicated that uncleaved COL1A1-PDGFB forms are mitogenic and therefore could contribute, as well as mature PDGFB, to the establishment of a transformed phenotype.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11420709     DOI: 10.1038/sj.onc.1204426

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

Review 1.  Targeted therapy for dermatofibrosarcoma protuberans.

Authors:  Thomas A Abrams; Scott M Schuetze
Journal:  Curr Oncol Rep       Date:  2006-07       Impact factor: 5.075

2.  Dermatofibrosarcoma Protuberans-Like Tumor With COL1A1 Copy Number Gain in the Absence of t(17;22).

Authors:  Jad Saab; Ian M Rosenthal; Lu Wang; Klaus J Busam; Kishwer S Nehal; Mark A Dickson; Meera R Hameed; Travis J Hollmann
Journal:  Am J Dermatopathol       Date:  2017-04       Impact factor: 1.533

3.  Stromal platelet-derived growth factor receptor α (PDGFRα) provides a therapeutic target independent of tumor cell PDGFRα expression in lung cancer xenografts.

Authors:  David E Gerber; Puja Gupta; Michael T Dellinger; Jason E Toombs; Michael Peyton; Inga Duignan; Jennifer Malaby; Timothy Bailey; Colleen Burns; Rolf A Brekken; Nick Loizos
Journal:  Mol Cancer Ther       Date:  2012-08-28       Impact factor: 6.261

Review 4.  Pediatric sarcomas: translating molecular pathogenesis of disease to novel therapeutic possibilities.

Authors:  Jennifer L Anderson; Christopher T Denny; William D Tap; Noah Federman
Journal:  Pediatr Res       Date:  2012-08       Impact factor: 3.756

5.  Imatinib mesylate in advanced dermatofibrosarcoma protuberans: pooled analysis of two phase II clinical trials.

Authors:  Piotr Rutkowski; Martine Van Glabbeke; Cathryn J Rankin; Wlodzimierz Ruka; Brian P Rubin; Maria Debiec-Rychter; Alexander Lazar; Hans Gelderblom; Raf Sciot; Dolores Lopez-Terrada; Peter Hohenberger; Allan T van Oosterom; Scott M Schuetze
Journal:  J Clin Oncol       Date:  2010-03-01       Impact factor: 44.544

6.  Atrophic dermatofibrosarcoma protuberans.

Authors:  Ola Bakry; Abdalla Attia
Journal:  J Dermatol Case Rep       Date:  2012-03-27

7.  Magnetic resonance imaging and mammographic appearance of dermatofibrosarcoma protuberans in a male breast: a case report and literature review.

Authors:  Xin Chen; Yung Hsin Chen; Yi-Li Zhang; You-Min Guo; Zhi-Lan Bai; Xian Zhao
Journal:  J Med Case Rep       Date:  2009-06-16

8.  Complex t(5;8) involving the CSPG2 and PTK2B genes in a case of dermatofibrosarcoma protuberans without the COL1A1-PDGFB fusion.

Authors:  Laurence Bianchini; Georges Maire; Bernard Guillot; Jean-Marie Joujoux; Philippe Follana; Marie-Pierre Simon; Jean-Michel Coindre; Florence Pedeutour
Journal:  Virchows Arch       Date:  2008-02-06       Impact factor: 4.064

Review 9.  Unusual presentation of dermatofibrosarcoma protuberans in a male patient's breast: a case report and review of the literature.

Authors:  Mohannad Al Tarakji; Adriana Toro; Isidoro Di Carlo; Kulsoon Junejo
Journal:  World J Surg Oncol       Date:  2015-04-22       Impact factor: 2.754

10.  Genetic aberrations in imatinib-resistant dermatofibrosarcoma protuberans revealed by whole genome sequencing.

Authors:  Jung Yong Hong; Xiao Liu; Mao Mao; Miao Li; Dong Il Choi; Shin Woo Kang; Jeeyun Lee; Yoon La Choi
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.